Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations
E. Rosalie Witjas‐Paalberends(Amsterdam UMC Location VUmc), Jolanda van der Velden(Amsterdam University Medical Centers), Cristobal G. dos Remedios(The University of Sydney), Michelle Michels(Erasmus MC), Arend F. L. Schinkel(Erasmus MC), Ger J.M. Stienen(Amsterdam UMC Location VUmc), Hendrik J. Harms(Amsterdam UMC Location VUmc), Paul Knaapen(Amsterdam University Medical Centers), Alexa M.C. Vermeer(Academic Medical Center), Corrado Poggesi(University of Florence), Imke Christiaans(Academic Medical Center), Marjon van Slegtenhorst(Erasmus MC), Adriaan A. Lammertsma(University Medical Center Groningen), Albert C. van Rossum(Amsterdam Neuroscience), Tjeerd Germans(Noordwest Ziekenhuisgroep), Carolyn Y. Ho(Brigham and Women's Hospital), Ahmet Güçlü(Amsterdam UMC Location VUmc), Arthur A.M. Wilde(Amsterdam Neuroscience)
Cited by 125
Related Papers
Genotype-Phenotype Correlation in the Long-QT Syndrome
|Circulation|2001|1.8k
Truncations of Titin Causing Dilated Cardiomyopathy
|New England Journal of Medicine|2012|1.5k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
|Circulation|2018|837
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
|New England Journal of Medicine|2010|706